Dose-escalation Study of GSK2330672 in Japanese Healthy Male Volunteers

NCT02801981 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Cholestasis

Interventions

DRUG: GSK2230672
DRUG: Placebo

Sponsor

GlaxoSmithKline